ACE2 and COVID-19: This is likely to occur in SARS-CoV-2 infection as well (Zhang et al. 2020c); supporting this, monocytes from COVID-19 patients displayed reduced ACE2 levels compared with non-infected controls (Zhang et al. 2020b).